title: Impaired Stat3 activation following localized inflammatory stimulus in IL-6-deficient mice.
abstract: Interleukin 6 (IL-6) and related gp130-signalling cytokines rapidly activate latent cytoplasmic Stat transcription factors and these are believed to play pivotal roles in the expression of downstream cytokine-responsive genes. We have previously shown in IL-6-deficient (-/-) mice that IL-6 is absolutely required for the transcriptional induction of acute phase response (APR) genes in the liver following localized tissue damage caused by subcutaneous injection of turpentine oil, but is not required when the inflammatory stimulus is administered systemically by intraperitoneal injection of bacterial lipopolysaccharide (LPS). In this paper we show that Stat3 is the only Stat factor induced in liver tissue upon localized inflammatory stimuli, and that its activation is virtually absent in IL-6 deficient mice. During LPS-induced inflammation both Stat1 and Stat3 are activated, and only minor kinetic alterations are detected in IL-6-/- mice. These defects are not due to altered intracellular signal transduction, since they could be complemented by injection of recombinant cytokines. These results establish a direct causal relationship in vivo between Stat activation and acute phase gene expression and define unique functions of IL-6 in Stat3 activation upon localized inflammation.
authors.affiliation: Istituto di Ricerche di Biologia Molecolare P. Angeletti (IRBM), Pomezia, Roma, Italy.
authors.forename: T
authors.initials: T
authors.lastname: Alonzi
authors.forename: E
authors.initials: E
authors.lastname: Fattori
authors.forename: M
authors.initials: M
authors.lastname: Cappelletti
authors.forename: G
authors.initials: G
authors.lastname: Ciliberto
authors.forename: V
authors.initials: V
authors.lastname: Poli
mesh_terms: D000209:Acute-Phase Proteins / Q000378:metabolism*; D000818:Animals; D004268:DNA-Binding Proteins / Q000378:metabolism*; D006505:Hepatitis / Q000378:metabolism*; D007371:Interferon-gamma / Q000494:pharmacology; D015850:Interleukin-6 / Q000172:deficiency / Q000378:metabolism* / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D051379:Mice; D053683:Oncostatin M; D010455:Peptides / Q000494:pharmacology; D012333:RNA, Messenger; D011994:Recombinant Proteins / Q000494:pharmacology; D050794:STAT1 Transcription Factor; D050796:STAT3 Transcription Factor; D013997:Time Factors; D015534:Trans-Activators / Q000378:metabolism*; D014425:Turpentine / Q000494:pharmacology; D000511:alpha-Macroglobulins / Q000378:metabolism
chemical_list: D000209:Acute-Phase Proteins; D004268:DNA-Binding Proteins; D015850:Interleukin-6; D008070:Lipopolysaccharides; C508352:Osm protein, mouse; D010455:Peptides; D012333:RNA, Messenger; D011994:Recombinant Proteins; D050794:STAT1 Transcription Factor; D050796:STAT3 Transcription Factor; C494080:Stat1 protein, mouse; C494087:Stat3 protein, mouse; D015534:Trans-Activators; D000511:alpha-Macroglobulins; D053683:Oncostatin M; D007371:Interferon-gamma; D014425:Turpentine